BMC Pharmacology and Toxicology | Home page

Advertisement

Featured article: Preventing angiogenesis inhibits oral cancer growth

New Content Item

Angiogenesis, the formation of new blood vessels from preexisting vessels, is critical for oral cancer development. Semaforin-3 (Sema3) is a secreted protein that prevents angiogenesis. Overexpression of Sema3 in oral tumor cell lines decreases tumor vasculature in vitro and decreases the size and capillary density of tumors in xenograft models of oral cancer in mice.

Featured collection: Neurometals

Flickr by Mike Seyfang

Metals have many essential functions in the brain and a large body of evidence supports important roles for altered metal stasis in many brain disorders. This article collection guest edited by Section Editor, Dr Michael Aschner provides a node for other researchers across diverse fields to access brain metal research and integrate this into their own programs.

Read More

Articles

Recent
Most accessed

Recent articles RSS

Research article

Evaluation of pharmacotherapy complexity in residents of long-term care facilities: a cross-sectional descriptive study

Vanessa Alves-Conceição, Daniel Tenório da Silva, Vanessa Lima de Santana, Edileide Guimarães dos Santos, Lincoln Marques Cavalcante Santos and Divaldo Pereira de Lyra Jr.

Published on: 25 July 2017
Research article

β adrenergic receptor/cAMP/PKA signaling contributes to the intracellular Ca²⁺ release by tentacle extract from the jellyfish Cyanea capillata

Qianqian Wang, Hui Zhang, Bo Wang, Chao Wang, Liang Xiao and Liming Zhang

Published on: 25 July 2017
Research article

Astaxanthin mitigates cobalt cytotoxicity in the MG-63 cells by modulating the oxidative stress

Dahe Li, Wenwen Tong, Denghui Liu, Yuming Zou, Chen Zhang and Weidong Xu

Published on: 24 July 2017
Research article

The inhibitory effect of Isoliquiritigenin on the proliferation of human arterial smooth muscle cell

Tianbao Chen, Shaoxiong Deng and Rong Lin

Published on: 17 July 2017
Study protocol

Zinc as an adjunct treatment for reducing case fatality due to clinical severe infection in young infants: study protocol for a randomized controlled trial

Nitya Wadhwa, Sudha Basnet, Uma Chandra Mouli Natchu, Laxman P. Shrestha, Shinjini Bhatnagar, Halvor Sommerfelt, Tor A. Strand, Siddarth Ramji, K. C. Aggarwal, Harish Chellani, Anuradha Govil, Mamta Jajoo, N. B. Mathur, Meenakshi Bhatt, Anup Mohta, Imran Ansari…

Published on: 10 July 2017

View all articles

Most accessed articles RSS

Review

A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study

Suzanne Dunne, Bill Shannon, Colum Dunne and Walter Cullen

Published on: 5 January 2013
Case report

Rifampicin-warfarin interaction leading to macroscopic hematuria: a case report and review of the literature

Maria AP Martins, Adriano MM Reis, Mariana F Sales, Vandack Nobre, Daniel D Ribeiro, Manoel OC Rocha and Antônio LP Ribeiro

Published on: 4 May 2013
Research article

Physiological and pharmacokinetic effects of oral 1,3-dimethylamylamine administration in men

Brian K Schilling, Kelley G Hammond, Richard J Bloomer, Chaela S Presley and Charles R Yates

Published on: 4 October 2013
Research article

Pharmaceutical quality of seven generic Levodopa/Benserazide products compared with original Madopar® / Prolopa®

Urs E Gasser, Anton Fischer, Jan P Timmermans and Isabelle Arnet

Published on: 23 April 2013
Research article

Comparing antibiotic self-medication in two socio-economic groups in Guatemala City: a descriptive cross-sectional study

Brooke M Ramay, Paola Lambour and Alejandro Cerón

Published on: 27 April 2015

View all articles

Aims and scope

BMC Pharmacology and Toxicology is an open access, peer-reviewed journal that considers articles on all aspects of chemically defined therapeutic and toxic agents. The journal welcomes submissions from all fields of experimental and clinical pharmacology including clinical trials.It is journal policy to publish work deemed by peer reviewers to be a coherent and sound addition to scientific knowledge and to put less emphasis on interest levels, provided that the research constitutes a useful contribution to the field.

Editor

Benjamin Ragen, BioMed Central

Section Editors

Michael Aschner, Albert Einstein College of Medicine
Phil Biggin, University of Oxford
Lucio Guido Costa, University of Washington
David H Farb, Boston University School of Medicine
Giorgio Palu, University of Padova
Catherine MT Sherwin, University of Utah

Catherine Sherwin, Section Editor

New Content Item

Dr. Catherine Sherwin is currently an Associate Professor

Meet our Section Editors

Data support service

Authors submitting to this journal can opt to use a new service that will make it easier to share research data.

Find out more

BMC Pharmacology

BMC Pharmacology and Toxicology assimilated the Editorial boards and history of BMC Pharmacology and BMC Clinical Pharmacology on fusion of the journals in 2012. The full archive of BMC Pharmacology is available from its own archive website, and the objectives and aspirations of the merged journal are explained in the editorial that accompanied the fusion. The full archive of BMC Clinical Pharmacology is available here.

BMC Series blog

Sugar-sweetened drinks and your metabolism

Published on: 21 July 2017
Accelerating ethics review during disease outbreaks: what we can learn from West Africa’s Ebola Outbreak

Published on: 20 July 2017
A taxonomic revolution? A Q&A with Sandy Knapp on the impact of e-publications

Published on: 17 July 2017

Tweets

Advertisement

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us

Editorial email: bmcpharmacoltoxicol@biomedcentral.com
Support email: info@biomedcentral.com